FDA Approved: PROCARDIA XL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)

View source ↗

Summary

FDA approved a supplemental application for Procardia XL (nifedipine) submitted by Pfizer Laboratories Div Pfizer Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Raynaud Phenomenon
• Stable Angina
• Vasospastic Angina

Drugs mentioned

• PROCARDIA XL (NIFEDIPINE)

Snippet

SUPPL AP for PROCARDIA XL (NIFEDIPINE)